| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |